from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2260/-

LFCtreatmentdescriptionclass of inhibitor

-1.778

Amikacinug/mL Amikacintranslation

-1.672

Cap5-10ug/mL Capreomycintranslation

-3.039

Rox10-50 ug/mL Roxithromycintranslation

-0.575

SM2-5 ug/mL Streptomycintranslation

-4.074

Tet5-10 ug/mL Tetracyclinetranslation

-1.019

Rif0.2-5ug/mL Rifampicintranscription

-1.412

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.387

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.669

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.469

CPZ10-50 ug/mL Chlorpromazinerespiration

0.848

Clofazimine10-13 ug/mL Clofaziminerespiration

0.938

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.095

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.750

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.063

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.071

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.516

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.795

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.400

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.881

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.154

KCN5-20 ug/mL Potassium cyaniderespiration

0.940

NaN30.2-2 mM Sodium aziderespiration

-0.024

Nigericin50 uM Nigericinrespiration

-0.423

TRC10-150 ug/mL Triclosanrespiration

-0.098

TRZ10-25 ug/mL Thioridazinerespiration

-1.997

Valinomycin0.5-10 uM Valinomycinrespiration

0.980

ZnSO42 mM ZnSO4respiration

0.904

menadione6-10 ug/mL Menadionerespiration

0.416

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.148

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.064

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.525

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.456

NRP_1Non-replicating persistence stage 1dosRassociated

-0.355

Amp0.2mg/mL AmpicillincellWall

-0.089

Cephalexin20-100 ug/mL CephalexincellWall

0.169

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.177

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.479

EMB10-20 ug/mL EthambutolcellWall

0.295

Eta12-40 ug/mL EthionamidecellWall

-0.172

INH0.2-0.4 ug/mL IsoniazidcellWall

0.558

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.004

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.234

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.059

BZA0.12 mg/mL BenzamidearomaticAmides

-0.018

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.066

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.399

H2O24 mM hydrogen peroxideDNAdamaging

0.410

Levo10 ug/mL LevofloxacinDNAdamaging

0.184

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.757

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.927

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.777

UVUV-irradiationDNAdamaging

0.946

ARP41-4 ug/mL Antitubercular compound ARP4?

0.713

Antimycin12.5-50 ug/mL Antimycin A?

0.413

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.630

PA_110-50 ug/mL Antitubercular compound PA-1?

0.599

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.237

PA8240.2-2 ug/mL PA-824?

0.545

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.659

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.386

Verapamil50 uM Verapamil?

0.545

mercaptoethanol2 mM 2-Mercaptoethanol?

0.616

methoxatin10-20 ug/mL Methoxatin?